We are live on ! Find out more
CLDX icon

Celldex Therapeutics
CLDX

76 hedge funds and large institutions have $365M invested in Celldex Therapeutics in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,008% more capital invested

Capital invested by funds: $7.15M → $365M (+$358M)

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

388% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 8

185% more call options, than puts

Call options by funds: $13.2M | Put options by funds: $4.61M

69% more funds holding

Funds holding: 45 → 76 (+31)

54.61% more ownership

Funds ownership: 22.58% → 77.19% (+55%)

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

Holders
76
Holders Change
+31
Holders Change %
+68.89%
% of All Funds
1.56%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.1%
New
39
Increased
12
Reduced
10
Closed
8
Calls
$13.2M
Puts
$4.61M
Net Calls
+$8.55M
Net Calls Change
+$8.38M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$12.1M
2
RI
RTW Investments
New York
+$11.6M
3
LGM
Logos Global Management
California
+$8.86M
4
RG
Redmile Group
California
+$8.86M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.76M

Top Sellers

Rank Fund Capital Flow
1
MG
Meditor Group
Bermuda
-$993K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$313K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$174K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$85.5K
5
BCM
Bridgeway Capital Management
Texas
-$83K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
26
Boothbay Fund Management
New York
$2.71M +$926K +208,836 New
MG
27
Meditor Group
Bermuda
$2.56M -$993K -224,000 -53%
Two Sigma Investments
28
Two Sigma Investments
New York
$1.7M +$581K +131,094 New
Geode Capital Management
29
Geode Capital Management
Massachusetts
$1.69M +$116K +26,254 +25%
DCM
30
Driehaus Capital Management
Illinois
$1.56M +$532K +120,000 New
GPCM
31
Granite Point Capital Management
Massachusetts
$1.42M +$484K +109,095 New
SM
32
Sabby Management
Florida
$950K +$324K +73,094 New
EI
33
EAM Investors
California
$899K +$306K +69,126 New
Simplex Trading
34
Simplex Trading
Illinois
$813K +$277K +62,592 New
Citadel Advisors
35
Citadel Advisors
Florida
$774K +$155K +34,997 +143%
ECM
36
ExodusPoint Capital Management
New York
$759K +$259K +58,415 New
Northern Trust
37
Northern Trust
Illinois
$744K +$102K +23,040 +67%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$729K +$248K +56,056 New
CIBC World Market
39
CIBC World Market
Ontario, Canada
$520K +$177K +40,000 New
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$472K +$161K +36,334 New
Creative Planning
41
Creative Planning
Kansas
$460K +$103K +23,200 +191%
Morgan Stanley
42
Morgan Stanley
New York
$301K +$16.1K +3,639 +19%
WG
43
Winton Group
United Kingdom
$252K +$32.7K +7,374 +61%
MCP
44
Mirador Capital Partners
California
$249K +$34.6K +7,802 +69%
RJFSA
45
Raymond James Financial Services Advisors
Florida
$200K -$7.03K -1,586 -9%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$180K -$85.5K -19,298 -58%
Jane Street
47
Jane Street
New York
$180K +$61.5K +13,876 New
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$156K – – –
TCM
49
Tekla Capital Management
Massachusetts
$92K – – –
Walleye Trading
50
Walleye Trading
New York
$74K +$25.3K +5,714 New
1
2
3 4

CLDX Hedge Fund Activity: Q2 2020 in Review

76 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Celldex Therapeutics (CLDX) for Q2 2020, worth a combined $365M — up 5,008% from $7.15M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CLDX positions and 8 closed out — a net gain of 31 holders — while 12 added to existing stakes and 10 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $12.1M. The largest seller was Meditor Group, cutting an estimated $993K.

  • 76 institutional investors held Celldex Therapeutics (CLDX) as of Q2 2020, up from 45 in Q1 2020.
  • Funds reported $365M of Celldex Therapeutics stock for Q2 2020, up 5,008% quarter-over-quarter.
  • 39 funds opened new Celldex Therapeutics positions in Q2 2020 and 8 closed out, a net change of +31 holders.
  • The largest Celldex Therapeutics buyer in Q2 2020 was BVF Inc, an estimated $12.1M added.
  • The largest Celldex Therapeutics seller in Q2 2020 was Meditor Group, an estimated $993K sold.

Based on aggregated 13F filings for Q2 2020.